$1.57 Billion is the total value of Eversept Partners, LP's 107 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
QQQ | New | INVESCO QQQ TRput | $114,023,810 | – | 286,600 | +100.0% | 7.28% | – |
BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $43,427,927 | – | 315,129 | +100.0% | 2.77% | – |
IWM | New | ISHARES TRput | $27,806,250 | – | 125,000 | +100.0% | 1.78% | – |
IWO | New | ISHARES TRput | $26,374,500 | – | 90,000 | +100.0% | 1.68% | – |
CLDX | New | CELLDEX THERAPEUTICS INC NEW | $22,893,350 | – | 592,478 | +100.0% | 1.46% | – |
ARKG | New | ARK ETF TRcall | $14,930,312 | – | 243,800 | +100.0% | 0.95% | – |
XBI | New | SPDR SER TRcall | $12,741,048 | – | 113,800 | +100.0% | 0.81% | – |
SYNH | New | SYNEOS HEALTH INCcl a | $8,790,640 | – | 85,612 | +100.0% | 0.56% | – |
PODD | New | INSULET CORP | $8,027,864 | – | 30,172 | +100.0% | 0.51% | – |
BIIB | New | BIOGEN INC | $7,927,197 | – | 33,041 | +100.0% | 0.51% | – |
CERN | New | CERNER CORP | $7,221,692 | – | 77,543 | +100.0% | 0.46% | – |
XENE | New | XENON PHARMACEUTICALS INC | $6,545,374 | – | 209,519 | +100.0% | 0.42% | – |
NVRO | New | NEVRO CORP | $5,356,619 | – | 66,074 | +100.0% | 0.34% | – |
ZNTL | New | ZENTALIS PHARMACEUTICALS INC | $5,309,482 | – | 63,163 | +100.0% | 0.34% | – |
MRK | New | MERCK & CO INC | $5,025,107 | – | 19,456 | +100.0% | 0.32% | – |
AUPH | New | AURINIA PHARMACEUTICALS INC | $4,605,652 | – | 201,384 | +100.0% | 0.29% | – |
CVAC | New | CUREVAC N V | $2,916,933 | – | 85,017 | +100.0% | 0.19% | – |
PGNY | New | PROGYNY INCput | $2,517,500 | – | 50,000 | +100.0% | 0.16% | – |
GRTS | New | GRITSTONE BIO INC | $2,187,808 | – | 170,125 | +100.0% | 0.14% | – |
ACAD | New | ACADIA PHARMACEUTICALS INCcall | $1,974,564 | – | 84,600 | +100.0% | 0.13% | – |
ESTA | New | ESTABLISHMENT LABS HLDGS INC | $1,699,010 | – | 25,137 | +100.0% | 0.11% | – |
UTHR | New | UNITED THERAPEUTICS CORP DELcall | $1,642,208 | – | 7,600 | +100.0% | 0.10% | – |
VCRA | New | VOCERA COMMUNICATIONS INC | $970,655 | – | 14,970 | +100.0% | 0.06% | – |
MRUS | New | MERUS N V | $604,200 | – | 19,000 | +100.0% | 0.04% | – |
CSU | New | SONIDA SENIOR LIVING INC | $433,304 | – | 15,209 | +100.0% | 0.03% | – |
BKD | New | BROOKDALE SR LIVING INC | $408,393 | – | 79,146 | +100.0% | 0.03% | – |
JYNT | New | JOINT CORPput | $361,295 | – | 5,500 | +100.0% | 0.02% | – |
MNKD | New | MANNKIND CORPcall | $218,500 | – | 50,000 | +100.0% | 0.01% | – |
GLYC | New | GLYCOMIMETICS INC | $144,000 | – | 100,000 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
AFFIMED N V | 20 | Q3 2023 | 0.9% |
ARGENX SE | 19 | Q3 2023 | 2.0% |
GSK PLC | 18 | Q2 2022 | 13.1% |
ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
SANOFI | 18 | Q4 2022 | 7.2% |
ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR/A | 2023-11-08 |
13F-HR/A | 2023-11-08 |
13F-HR/A | 2023-11-08 |
13F-HR/A | 2023-11-08 |
13F-HR/A | 2023-11-08 |
13F-HR/A | 2023-11-08 |
13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.